A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Stopped Terminated for futility by sponsor after a pre-planned interim review of data

Conditions

• Osteoporosis

Interventions

• DRUG: Ronacaleret
• DRUG: Teriparatide
• DRUG: Alendronate

Sponsor

GlaxoSmithKline